Epirubicin vs epirubicin plus cisplatin vs epirubicin plus lonidamine vs epirubicin plus cisplatin plus lonidamine as first line treatment in advanced breast cancer (BC) patients. A randomized multicenter phase III trial with a factorial design.
ANNALS OF ONCOLOGY(2000)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要